High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome

European Journal of Endocrinology

Volumn 150, Issue 3, 2004, Pages 363-369

  Janssen, Onno E ^c   Mehlmauer, Nadine ^b   Hahn, Susanne ^c   Öffner, Alexandra H ^a   Gärtner, Roland ^b  

^a Klinikum Schwabing   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; FOLLITROPIN; LEVOTHYROXINE; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROTROPIN;

ADOLESCENT; ADULT; AMENORRHEA; ANDROGEN SYNTHESIS; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; ECHOGRAPHY; ESTROGEN SYNTHESIS; FEMALE; FOLLITROPIN BLOOD LEVEL; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HYPERANDROGENISM; HYPOTHYROIDISM; IMMUNOASSAY; INCIDENCE; LABORATORY TEST; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PROGESTERONE; PROSPECTIVE STUDIES; TESTOSTERONE; THYROGLOBULIN; THYROID HORMONES; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 1842422388     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1500363     Document Type: Article

References (53)

1. Hayashi N, Tamaki N, Konishi J, Yonekura Y, Senda M, Kasagi K et al. Sonography of Hashimoto's thyroiditis. Journal of Clinical Ultrasound 1986 14 123-126.
2. Idris I & O'Malley BP. Thyrotoxicosis in Down's and Turner's syndromes: The likelihood of Hashimoto's thyroiditis as the underlying aetiology. International Journal of Clinical Practice 2000 54 272-273.
3. Boehm BO, Kuhnl P, Loliger C, Ketzler-Sasse U, Holzberger G, Seidl S et al. HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors. Clinical Investigation 1993 71 221-225.
4. Braun J, Donner H, Siegmund T, Walfish PG, Usadel KH & Badenhoop K. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens 1998 51 563-566.
5. Olsen NJ & Kovacs WJ. Gonadal steroids and immunity. Endocrine Reviews 1996 17 369-384.
6. Paavonen T. Hormonal regulation of immune responses. Annals of Medicine 1994 26 255-258.
7. Ahmed SA, Hissong BD, Verthelyi D, Donner K, Becker K & Karpuzoglu-Sahin E. Gender and risk of autoimmune diseases: Possible role of estrogenic compounds. Environmental Health Perspectives 1999 107 (Suppl 5) 681-686.
8. Tornwall J, Carey AB, Fox RI & Fox HS. Estrogen in autoimmunity: Expression of estrogen receptors in thymic and autoimmune T cells. Journal of Gender Specific Medicine 1999 2 33-40.
9. Falcone M & Sarvetnick N. Cytokines that regulate autoimmune responses. Current Opinion in Immunology 1999 11 670-676.
10. Angstwurm MW, Gartner R & Ziegler-Heitbrock HW. Cyclic plasma IL-6 levels during normal menstrual cycle. Cytokine 1997 9 370-374.
11. Cutolo M & Wilder RL. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheumatic Disease Clinics of North America 2000 26 825-839.
12. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR & Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. Journal of Clinical Endocrinology and Metabolism 1998 83 3078-3082.
13. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438.
14. Ferriman D & Gallwey JD. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961 21 1440-1447.
15. Carmina E & Lobo RA. A comparison of the relative efficacy of antiandrogens for the treatment of acne in hyperandrogenic women. Clinical Endocrinology 2002 57 231-234.
16. Carmina E & Lobo RA. Treatment of hyperandrogenic alopecia in women. Fertility and Sterility 2003 79 91-95.
17. Fox R & Hull M. Ultrasound diagnosis of polycystic ovaries. Annals of the New York Academy of Sciences 1993 687 217-223.
18. Hermans M, Levy J, Morris R & Turner R. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes. Diabetologia 1999 42 678-687.
19. Dunaif A & Thomas A. Current concepts in the polycystic ovary syndrome. Annual Review of Medicine 2001 52 401-419.
20. Kovacs G & Wood C. The current status of polycystic ovary syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology 2001 41 65-68.
21. Crosignani PG & Nicolosi AE. Polycystic ovarian disease: heritability and heterogeneity. Human Reproduction Update 2001 7 3-7.
22. Reinhardt W, Kohl S, Hollmann D, Klapp G, Benker G, Reinwein D et al. Efficacy and safety of iodine in the postpartum period in an area of mild iodine deficiency. European Journal of Medical Research 1998 3 203-210.
23. Nohr SB, Jorgensen A, Pedersen KM & Laurberg P. Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: Is iodine supplementation safe? Journal of Clinical Endocrinology and Metabolism 2000 85 3191-3198.
24. Knudsen N, Jorgensen T, Rasmussen S, Christiansen E & Perrild H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clinical Endocrinology 1999 51 361-367.
25. Knudsen N, Bulow I, Jorgensen T, Laurberg P, Ovesen L & Perrild H. Comparative study of thyroid function and types of thyroid dysfunction in two areas in Denmark with slightly different iodine status. European Journal of Endocrinology 2000 143 485-491.
26. Massoudi MS, Meilahn EN, Orchard TJ, Foley TP Jr, Kuller LH, Costantino JP et al. Thyroid function and perimenopausal lipid and weight changes: The Thyroid Study in Healthy Women (TSH-W). Journal of Womens Health 1997 6 553-558.
27. Pedersen IB, Knudsen N, Jorgensen T, Perrild H, Ovesen L & Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clinical Endocrinology 2003 58 36-42.
28. Tomimori E, Pedrinola F, Cavaliere H, Knobel M & Medeiros-Neto G. Prevalence of incidental thyroid disease in a relatively low iodine intake area. Thyroid 1995 5 273-276.
29. Wu X, Zhang Z & Su Y. [Functional states of pituitary-ovary, -adrenal and -thyroid axes in women with polycystic ovarian syndrome]. Zhonghua Fu Chan Ke Za Zhi 1998 33 153-156.
30. Zironi C, Pantaleoni M, Zizzo G, Coletta F & Velardo A. [Evaluation of dopaminergic activity of the hypothalamus in patients with polycystic ovarian syndrome]. Minerva Ginecologica 1991 43 443-447.
31. Tudose TI, Zelenetskaia VS, Kozlov GI, Pishchulin AA & Dobracheva AD. [Lactotropic and thyrotropic functions of the hypophysis in polycystic ovary syndrome]. Problemy Endokrinologii 1986 32 3-7.
32. Duignan NM. Polycystic ovarian disease. British Journal of Obstetrics and Gynaecology 1976 83 593-602.
33. Gulekli B, Turhan NO, Senoz S, Kukner S, Oral H & Gokmen O. Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients: A comparative study. Gynecological Endocrinology 1993 7 273-277.
34. Matsuoka LY, Wortsman J, Gavin JR & Goldman J. Spectrum of endocrine abnormalities associated with acanthosis nigricans. American Journal of Medicine 1987 83 719-725.
35. Carretti N & Prendin G. [Relations between thyroid and ovarian function: Estrogenism and basal metabolism]. Attualita di Ostetricia e Ginecologia 1968 1 111-120.
36. Goi R, Matsuda M, Maekawa H, Ogawa T & Sakata S. Two cases of Hashimoto's thyroiditis with transient hypothyroidism. Internal Medicine Journal of Thailand 1992 31 64-68.
37. Sridhar GR & Nagamani G. Hypothyroidism presenting with polycystic ovary syndrome. Journal of the Association of Physicians of India 1993 41 88-90.
38. Barbesino G & Chiovato L. The genetics of Hashimoto's disease. Endocrinology and Metabolism Clinics of North America 2000 29 357-374.
39. Franks S, Gharani N & McCarthy M. Candidate genes in polycystic ovary syndrome. Human Reproduction Update 2001 7 405-410.
40. Colilla S, Cox NJ & Ehrmann DA. Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives. Journal of Clinical Endocrinology and Metabolism 2001 86 2027-2031.
41. Venkatesan AM, Dunaif A & Corbould A. Insulin resistance in polycystic ovary syndrome: Progress and paradoxes. Recent Progress in Hormone Research 2001 56 295-308.
42. Tapanainen JS, Koivunen R, Fauser BC, Taylor AE, Clayton RN, Rajkowa M et al. A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. Journal of Clinical Endocrinology and Metabolism 1999 84 1711-1715.
43. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. PNAS 1999 96 8573-8578.
44. Reimand K, Talja I, Metskula K, Kadastik U, Matt K & Uibo R. Autoantibody studies of female patients with reproductive failure. Journal of Reproductive Immunology 2001 51 167-176.
45. Fenichel P, Gobert B, Carre Y, Barbarino-Monnier P & Hieronimus S. Polycystic ovary syndrome in autoimmune disease. Lancet 1999 353 2210.
46. Roussev RG, Kaider BD, Price DE & Coulam CB. Laboratory evaluation of women experiencing reproductive failure. American Journal of Reprodutive Immunology 1996 35 415-420.
47. van Gelderen CJ & Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. Journal of Reproductive Medicine 1993 38 381-386.
48. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Current Opinion in Rheumatology 1999 11 352-356.
49. Lonsdale RN, Roberts PF & Trowell JE. Autoimmume oophoritis associated with polycystic ovaries. Histopathology 1991 19 77-81.
50. Bussen S, Steck T & Dietl J. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Human Reproduction 2000 15 545-548.
51. Wakim AN, Polizotto SL & Burholt DR. Augmentation by thyroxine of human granulosa cell gonadotrophin-induced steroidogenesis. Human Reproduction 1995 10 2845-2848.
52. Rotmensch S & Scommegna A. Spontaneous ovarian hyperstimulation syndrome associated with hypothyroidism. American Journal of Obstetrics and Gynecology 1989 160 1220-1222.
53. Hansen KA, Tho SP, Hanly M, Moretuzzo RW & McDonough PG. Massive ovarian enlargement in primary hypothyroidism. Fertility and Sterility 1997 67 169-171.